Lacroix-Desmazes S - Search Results

1

A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope.

Dimitrov JD, Roumenina LT, Plantier JL, Andre S, Saboulard D, Meslier Y, Planchais C, Jacquemin M, Saint-Remy JM, Atanasov BP, Kaveri SV, Lacroix-Desmazes S. Dimitrov JD, et al. J Thromb Haemost. 2010 Jul;8(7):1524-31. doi: 10.1111/j.1538-7836.2010.03878.x. Epub 2010 Mar 30. J Thromb Haemost. 2010. PMID: 20374449 Free article.

2

Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A.

Navarrete A, Dasgupta S, Delignat S, Caligiuri G, Christophe OD, Bayry J, Nicoletti A, Kaveri SV, Lacroix-Desmazes S. Navarrete A, et al. J Thromb Haemost. 2009 Nov;7(11):1816-23. doi: 10.1111/j.1538-7836.2009.03571.x. Epub 2009 Aug 11. J Thromb Haemost. 2009. PMID: 19682235 Free article.

3

Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells.

Meslier Y, André S, Dimitrov JD, Delignat S, Bayry J, Kaveri SV, Lacroix-Desmazes S. Meslier Y, et al. J Thromb Haemost. 2011 Apr;9(4):719-28. doi: 10.1111/j.1538-7836.2011.04200.x. J Thromb Haemost. 2011. PMID: 21251202 Free article.

4

Heme binds to factor VIII and inhibits its interaction with activated factor IX.

Repessé Y, Dimitrov JD, Peyron I, Farrokhi Moshai E, Kiger L, Dasgupta S, Delignat S, Marden MC, Kaveri SV, Lacroix-Desmazes S. Repessé Y, et al. J Thromb Haemost. 2012 Jun;10(6):1062-71. doi: 10.1111/j.1538-7836.2012.04724.x. J Thromb Haemost. 2012. PMID: 22471307 Free article.

5

Role of coagulation-associated processes on factor VIII immunogenicity in a mouse model of severe hemophilia A.

Gangadharan B, Delignat S, Ollivier V, Gupta N, Mackman N, Kaveri SV, Lacroix-Desmazes S. Gangadharan B, et al. J Thromb Haemost. 2014 Dec;12(12):2065-9. doi: 10.1111/jth.12740. Epub 2014 Oct 25. J Thromb Haemost. 2014. PMID: 25267332 Free article.

6

Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG.

Moreau A, Lacroix-Desmazes S, Stieltjes N, Saenko E, Kaveri SV, D'Oiron R, Sultan Y, Scandella D, Kazatchkine MD. Moreau A, et al. Blood. 2000 Jun 1;95(11):3435-41. Blood. 2000. PMID: 10828026 Free article.

7

Natural antibodies to factor VIII.

Lacroix-Desmazes S, Moreau A, Pashov A, Sooryanarayana, Stahl D, Saint-Remy JM, Kaveri SV, Kazatchkine MD. Lacroix-Desmazes S, et al. Semin Thromb Hemost. 2000;26(2):157-65. doi: 10.1055/s-2000-9818. Semin Thromb Hemost. 2000. PMID: 10919408 Review.

8

Idiotypic regulation of anti-factor VIII antibodies.

Kazatchkine MD, Lacroix-Desmazes S, Moreau A, Kaveri SV. Kazatchkine MD, et al. Haematologica. 2000 Oct;85(10 Suppl):97-9. Haematologica. 2000. PMID: 11187885 Review.

9

The concept of idiotypic vaccination against factor VIII inhibitors in haemophilia A.

Lacroix-Desmazes S, Bayry J, Misra N, Kaveri SV, Kazatchkine MD. Lacroix-Desmazes S, et al. Haemophilia. 2002 Mar;8 Suppl 2:55-9. doi: 10.1046/j.1351-8216.2001.00116.x. Haemophilia. 2002. PMID: 11966855 Review.

10

Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.

Kaveri SV, Dasgupta S, Andre S, Navarrete AM, Repessé Y, Wootla B, Lacroix-Desmazes S. Kaveri SV, et al. Haemophilia. 2007 Dec;13 Suppl 5:61-4. doi: 10.1111/j.1365-2516.2007.01575.x. Haemophilia. 2007. PMID: 18078399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters